Modulatory Effects of Ferulic Acid on Cadmium-Induced Brain Damage

Journal of Evidence-Based Complementary and Alternative Medicine

Volumn 21, Issue 4, 2016, Pages NP56-NP61

  Adefegha, Stephen A ^a   Omojokun, Olasunkanmi S ^a   Oboh, Ganiyu ^a   Fasakin, Olasunkanmi ^a   Ogunsuyi, Opeyemi ^a  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

cadmium; cholinesterases; ferulic acid; malondialdehyde; monoamine oxidase; Na+ K+ ATPase

Indexed keywords

ANTIOXIDANT; CADMIUM; COUMARIC ACID; FERULIC ACID;

ANIMAL; BRAIN; BRAIN CHEMISTRY; BRAIN INJURY; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; LIPID PEROXIDATION; MALE; METABOLISM; RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BRAIN; BRAIN CHEMISTRY; BRAIN INJURIES; CADMIUM; COUMARIC ACIDS; LIPID PEROXIDATION; MALE; RATS; RATS, WISTAR;

EID: 84989216820     PISSN: 21565872     EISSN: None     Source Type: Journal    
DOI: 10.1177/2156587215621726     Document Type: Article

References (27)

1. Del-Pino J, Zeballos G, Anadon MJ. Higher sensitivity to cadmium induced cell death of basal forebrain cholinergic neurons: a cholinesterase dependent mechanism. Toxicology. 2014;325:151–159.
2. Jahan S, Zahra A, Irum U, Iftikhar N, Ullah H. Protective effects of different antioxidants against cadmium induced oxidative damage in rat testis and prostate tissues. Syst Biol Reprod Med. 2014;60:199–205.
3. Tarasub N, Tarasub C, Ayutthaya WDN. Protective role of curcumin on cadmium-induced nephrotoxicity in rats. J Environ Chem Ecotoxicol. 2011;3(2):17–24.
4. Mancuso C, Santangelo R. Ferulic acid: pharmacological and toxicological aspects. Food Chem Toxicol. 2014;65:185–195.
5. Poquet L, Clifford MN, Williamson G. Transport and metabolism of ferulic acid through the colonic epithelium. Drug Metab Dispos. 2008;36:190–197.
6. Zhao Z, Egashira Y, Sanada H. Ferulic acid is quickly absorbed from rat stomach as the free form and then conjugated mainly in liver. J Nutr. 2004;134:3083–3088.
7. Srinivasan M, Rukkumani R, Ram Sudheer A, Menon VP. Ferulic acid, a natural protector against carbon tetrachloride-induced toxicity. Fundam Clin Pharmacol. 2005;19:491–496.
8. Roy S, Metya SK, Sannigrahi S, Rahaman N, Ahmed F. Treatment with ferulic acid to rats with streptozotocin-induced diabetes: effects on oxidative stress, pro-inflammatory cytokines, and apoptosis in the pancreatic β-cell. Endocrine. 2013;44:369–379.
9. Calabrese V, Bates TE, Stella AMG. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem Res. 2000;25:1315–1341.
10. Wuwongse S, Chang RCC, Law AC. The putative neurodegenerative links between depression and Alzheimer’s disease. Progr Neurobiol. 2010;91:362–375.
11. 2+-ATPase activities. J Ethnopharmacol. 2009;121:117–122.
12. +-ATPase and acetylcholinesterase activities by subchronic treatment with Casearia sylvestris. Phytomedicine. 2006;13:509–514.
13. Moneim AEA, Bauomy AA, Diab MM, Shata MTM, Al-Olayan EM, El-Khadragy MF. The protective effect of Physalis peruviana L. against cadmium-induced neurotoxicity in rats. Biol Trace Elem Res. 2014;160:392–399.
14. Trombino S, Cassano R, Ferrarelli T, Barone E, Picci N, Mancuso C. Trans-ferulic acid-based solid lipid nanoparticles and their antioxidant effect in rat brain microsomes. Colloids Surf B Biointerfaces. 2013;109:273–279.
15. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358.
16. Turski WA, Cavalheiro EA, Schwarz M, Czuczar SJ, KleinrokTurski L. Limbic seizures produced by pilocarpine rats—behavioural, electroencephalographic and neuropathological study. Behav Brain Res. 1983;9:315–335.
17. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95.
18. +-ATPase activity in cerebral cortex of rats. Neuroreport. 2000;11:2331–2334.
19. Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: therapeutic potential through its antioxidant property. J Clin Biochem Nutr. 2007;40:92–100.
20. Zhao Z, Moghadasian MH. Chemistry, natural sources, dietary intake and pharmacokinetic properties of ferulic acid: a review. Food Chem. 2008;109:691–702.
21. Devasagayam TPA, Boloor KK, Ramsarma T. Methods for estimating lipid peroxidation: analysis of merits and demerits (minireview). Indian J Biochem Biophys. 2003;40:300–308.
22. Raha S, Robinson BH. Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem Sci. 2000;25:502–508.
23. Thomas T. Monoamine oxidase-B inhibitors in the treatment of Alzheimer’s disease. Neurobiol Aging. 2000;21:343–348.
24. Ademosun AO, Oboh G. Comparison of the inhibition of monoamine oxidase and butyrylcholinesterase activities by infusions from green tea and some citrus peels. Int J Alzheimers Dis. 2014;2014:586407.
25. Bayır H, Kochanek PM, Kagan VE. Oxidative stress in immature brain after traumatic brain injury. Dev Neurosci. 2006;28:420–431.
26. Youdim MB, Edmondson D, Tipton KF. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci. 2006;7:295–309.
27. Greig NH, Utsuki T, Yu QS. A new therapeutic target in Alzheimer’s disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin. 2001;17:159–165.